Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Horni Predmesti

18 clinical trials in Horni Predmesti, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Horni Predmesti at a glance
18
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

18 trials in Horni Predmesti

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.

Cardiac failure

Recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:CzechiaCzechia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not yet recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Arteriosclerosis

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Horni Predmesti

What the registry says about research in the country

01 Cardiovascular Disease Management

Innovative research focusing on cardiovascular disease prevention and treatment, with studies evaluating new therapeutic approaches for reducing major cardiovascular events.

  • Lipoprotein Management
  • Cardiovascular Risk Reduction
  • Preventive Cardiology

Advanced trials exploring novel treatments for atherosclerotic cardiovascular disease prevention.

02 Lipid Disorders

Comprehensive studies addressing various forms of lipid disorders, including trials for hypertriglyceridemia and hypercholesterolemia management.

  • Triglyceride Level Control
  • Cholesterol Management
  • Innovative Lipid Therapies

Multiple trials evaluating new compounds for improving lipid profiles and patient outcomes.

03 Cardiac Rhythm Management

Specialized research focusing on atrial fibrillation treatments, including comparative studies of novel anticoagulation approaches.

  • Stroke Prevention
  • Anticoagulation Therapy
  • Heart Rhythm Control

Groundbreaking studies examining new therapeutic options for patients with irregular heart rhythms.

04 Heart Failure Research

Clinical investigations targeting heart failure treatment through combination therapy approaches and innovative drug development.

  • Combination Therapies
  • Heart Function Improvement
  • Quality of Life Assessment

Evaluating novel therapeutic combinations to enhance outcomes in heart failure patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.